CZ20023966A3 - Sůl thiazolidindionu pro léčbu diabetes mellitus - Google Patents

Sůl thiazolidindionu pro léčbu diabetes mellitus Download PDF

Info

Publication number
CZ20023966A3
CZ20023966A3 CZ20023966A CZ20023966A CZ20023966A3 CZ 20023966 A3 CZ20023966 A3 CZ 20023966A3 CZ 20023966 A CZ20023966 A CZ 20023966A CZ 20023966 A CZ20023966 A CZ 20023966A CZ 20023966 A3 CZ20023966 A3 CZ 20023966A3
Authority
CZ
Czechia
Prior art keywords
hydrobromide
solvate
pyridyl
ethoxy
methyl
Prior art date
Application number
CZ20023966A
Other languages
Czech (cs)
English (en)
Inventor
Andrew Simon Graig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of CZ20023966A3 publication Critical patent/CZ20023966A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CZ20023966A 2000-06-08 2001-06-08 Sůl thiazolidindionu pro léčbu diabetes mellitus CZ20023966A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
CZ20023966A3 true CZ20023966A3 (cs) 2003-04-16

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20023966A CZ20023966A3 (cs) 2000-06-08 2001-06-08 Sůl thiazolidindionu pro léčbu diabetes mellitus

Country Status (23)

Country Link
EP (1) EP1296980A1 (no)
JP (1) JP2003535862A (no)
KR (1) KR20030007918A (no)
CN (1) CN1443186A (no)
AP (1) AP2002002673A0 (no)
AU (1) AU2001264078A1 (no)
BG (1) BG107357A (no)
BR (1) BR0111536A (no)
CA (1) CA2411065A1 (no)
CZ (1) CZ20023966A3 (no)
DZ (1) DZ3382A1 (no)
EA (1) EA200300005A1 (no)
GB (1) GB0014006D0 (no)
HU (1) HUP0301137A3 (no)
IL (1) IL153279A0 (no)
MA (1) MA25753A1 (no)
MX (1) MXPA02012100A (no)
NO (1) NO20025883L (no)
OA (1) OA12284A (no)
PL (1) PL360592A1 (no)
SK (1) SK17142002A3 (no)
WO (1) WO2001094344A1 (no)
ZA (1) ZA200209954B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
EP2016076A2 (en) * 2007-01-22 2009-01-21 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
BG107357A (bg) 2003-08-29
CA2411065A1 (en) 2001-12-13
GB0014006D0 (en) 2000-08-02
BR0111536A (pt) 2003-07-01
ZA200209954B (en) 2003-10-10
NO20025883D0 (no) 2002-12-06
HUP0301137A2 (hu) 2003-08-28
DZ3382A1 (fr) 2001-12-13
SK17142002A3 (sk) 2003-10-07
EA200300005A1 (ru) 2003-04-24
NO20025883L (no) 2003-02-03
HUP0301137A3 (en) 2005-04-28
WO2001094344A1 (en) 2001-12-13
AU2001264078A1 (en) 2001-12-17
AP2002002673A0 (en) 2002-12-31
MXPA02012100A (es) 2003-04-25
EP1296980A1 (en) 2003-04-02
CN1443186A (zh) 2003-09-17
MA25753A1 (fr) 2003-04-01
OA12284A (en) 2003-11-10
JP2003535862A (ja) 2003-12-02
KR20030007918A (ko) 2003-01-23
IL153279A0 (en) 2003-07-06
PL360592A1 (en) 2004-09-20

Similar Documents

Publication Publication Date Title
SK286399B6 (sk) V podstate nehydratovaná a nehygroskopická alebo iba mierne hygroskopická hydrochloridová soľ 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
CZ20023966A3 (cs) Sůl thiazolidindionu pro léčbu diabetes mellitus
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
CZ300653B6 (cs) Dihydrát 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl}thiazolidin-2,4-dion-hydrochloridu, zpusob jeho prípravy a použití a farmaceutický prostredek s jeho obsahem
US20040034066A1 (en) Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]thiazolidine-2,4-dione
CZ20024029A3 (cs) Hydrojodid 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)-benzyl)thiazolidin-2,4-dionu jako léčivo
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
US20040014791A1 (en) Thiazolidinedione derivative and its use as antidiabetic
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
CZ2003314A3 (cs) Derivát thiazolidindionu ve formě soli kyseliny vinné
EP1795531A1 (en) A thiazolidinedione derivative and its use as antidiabetic
US20030162815A1 (en) Thiazolidinedione salt for treatment of diabetes mellitus
KR20040062963A (ko) 5-(4-(2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시)벤질)티아졸리딘-2,4-디온 벤젠술포네이트, 그의 제조 방법, 그의다형체 ⅰ, ⅱ 및 ⅲ, 및 제약상 활성 성분으로서의 그의용도